Making transplantation possible
VERIGRAFT uses a proprietary patent-protected technology to make donated tissue resemble the patient’s own. This personalized tissue is tailored to the patient and can be implanted without rejection. VERIGRAFT’s primary therapeutic focus areas are vascular repair, reconstruction and replacement. Learn more below.
The innovation in brief
Tissue donation
VERIGRAFT makes it possible to use donated tissue that would otherwise go to waste. In this way the gift of donation is honored.
Tissue personalization
VERIGRAFT’s proprietary technology removes components that would be recognized as foreign by the patient’s immune system and replaces them by the patient’s own biological material.
Implantation to the patient
The personalized tissue is implanted to the patient. Personalization minimizes the risk of tissue rejection by the patient’s immune system.
The solution in 7 steps
Therapeutic areas
VERIGRAFT focuses on four therapeutic areas; Veins, arteries, peripheral nerves and heart valves. The first clinical application is to treat Chronic Venous Insufficiency, CVI. VERIGRAFT’s lead product, the personalized tissue-engineered vein or P-TEVTM, is currently in clinical development.
Pipeline
VERIGRAFT’s revolutionary technology for personalized tissue has the potential to treat a wide range of indications. The development phase for the product candidates Personalized Tissue-Engineered Veins (P-TEVTM), Personalized Tissue-Engineered Arteries (P-TEATM), Personalized Tissue-Engineered Nerves (P-TENTM) and Personalized Tissue-Engineered Heart Valves (P-TEHVTM) currently range from pre-clinical to clinical development.
Product development for regenerative medicine
Indication
Pre-clinical
Phase I
Phase II